Markets:

Overview

News

Currencies

International

Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.3200 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

It’s Time to Start Thinking Seriously About Vaxart ↗

September 22, 2021

While VXRT stock is risky due to underlying clinical challenges, the evolving nature of Covid-19 makes it worth consideration.

Via InvestorPlace

Topics Government

Vaxart Looks To Be On The Verge Of Breaking Out Of A Pattern ↗

September 13, 2021

Vaxart Inc. (NASDAQ: VXRT) shares are trading lower Monday, possibly after retail traders were able to push the stock higher. The stock looks to be almost breaking out of a...

Via Benzinga

Vaxart Stock Is One Vaccine Also-Ran Worth Another Look ↗

September 08, 2021

The jury's out whether its oral Covid-19 vaccine will be successful, but VXRT stock may still be worth it as a speculative play.

Via InvestorPlace

Is Vaxart Stock Really Worth a Shot? ↗

August 30, 2021

VXRT stock still has hope as Vaxart is developing modern rDNA vaccines in pill form (including a Covid-19 vaccine).

Via InvestorPlace

Longshot Covid Play Vaxart Stock Is Too Risky at These Prices ↗

August 27, 2021

Vaxart got approval Aug. 2 for a Phase II trial for its oral Covid-19 vaccine. VXRT stock has gained since, but it's still too pricey.

Via InvestorPlace

Unusual Options Activity Insight: Vaxart ↗

August 11, 2021

Vaxart (NASDAQ:VXRT) shares experienced unusual options ac...

Via Benzinga

Unusual Options Activity Insight: Vaxart ↗

August 10, 2021

Shares of Vaxart (NASDAQ:VXRT) saw some unusual options a...

Via Benzinga

Vaxart Is Another Risky Biotech Stock to Avoid Right Now ↗

August 17, 2021

VRXT stock is highly overvalued. Investors are holding out for its Covid-19 vaccine, but it may not be approved in time to boost shares.

Via InvestorPlace

The Delta Variant Is a Shot in the Arm for Vaxart’s Pill Vaccine ↗

August 10, 2021

With many unvaccinated and the Delta variant a growing danger, VXRT stock has a good chance to increase in value in the coming future.

Via InvestorPlace

Vaxart Stock Probably Isn’t Worth the Risk as It Pushes Higher ↗

August 10, 2021

Vaxart’s oral recombinant vaccines are an interesting approach. Whether they do anything for VXRT stock remains to be seen.

Via InvestorPlace

Why Shares of Vaxart Are Soaring Today ↗

August 09, 2021

Some encouraging news for this troubled biotech.

Via The Motley Fool

28 Stocks Moving in Friday's Pre-Market Session ↗

August 06, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to acquire exclusive rights for assignment of...

Via Benzinga

The Bull Thesis for VXRT Stock is Questionable at Best ↗

August 03, 2021

Vaxart is far too risky for far too little

Via InvestorPlace

California and NYC Order Mandatory COVID-19 Testing Among Municipal Workers

August 03, 2021

Via FinancialNewsMedia

Why Vaxart's Stock Price Is Being Compressed In A Pennant Pattern And Looks Ready To Break Soon ↗

August 02, 2021

Vaxart Inc. (NASDAQ: VXRT) shares pushed higher Monday after the company made an announcement stating the U.S. Food and Drug Administration cleared its Investigational New Drug...

Via Benzinga

VXRT Stock: The Big FDA News Sending Vaxart Shooting Higher Today ↗

August 02, 2021

VXRT stock is bulking up today. The company is getting approval from the FDA regarding its Covid vaccine, allowing for further research.

Via InvestorPlace

Vaxart Stock Is Trading Higher As FDA Clears Mid-Stage Trial For S-Only Oral COVID-19 Vaccine Candidate ↗

August 02, 2021

The FDA has signed off Vaxart Inc's (NASDAQ: VXRT) Investigational New Drug application for an S-only oral tablet SARS-CoV-2 vaccine candidate. "This is...

Via Benzinga

Why Vaxart's Stock Is Trading Higher Today ↗

August 02, 2021

Vaxart Inc (NASDAQ: VXRT) is trading higher Monday morning after the company announced the U.S. Food and Drug Administration cleared its Investigational New Drug...

Via Benzinga

Understanding Vaxart's Unusual Options Activity ↗

July 29, 2021

Shares of Vaxart (NASDAQ:VXRT) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $7.91. Sentiment: BEARISH Option...

Via Benzinga

Vaxart Stock Shoots Higher After Its Oral Vaccine Boosts Immune Response In Previously Vaccinated Subject ↗

July 29, 2021

Vaxart Inc's (NASDAQ: VXRT) has disclosed data from a 12-subject Phase 1b blinded study evaluating the ability of its oral norovirus vaccine to boost...

Via Benzinga

Why Vaxart's Stock Is Surging Higher Today ↗

July 29, 2021

Vaxart Inc (NASDAQ: VXRT) is trading higher Thursday morning after the company announced that it has shown, for the first time in clinical trials, that its oral tablet...

Via Benzinga

Vaxart Stock Has Built-In Value Well Beyond Its Covid Pill ↗

July 26, 2021

You can buy VXRT stock for the company's tablet-based Covid-19 vaccine, and hold it for Vaxart's other clinical breakthroughs.

Via InvestorPlace

Vaxart Is Gaining Relevance, But Its Future Is Still Uncertain ↗

July 22, 2021

Vaxart may have a second chance at prominence with its Covid-19 vaccine pill. But VXRT stock is still a largely speculative buy.

Via InvestorPlace

Why Shares of Vaxart Jumped 31.2% in the First Half of 2021 ↗

July 19, 2021

The first half has been a cycle of hope and disappointment for shareholders.

Via The Motley Fool

Why Coronavirus Stocks Are Zooming Higher Today ↗

July 19, 2021

The surge in cases and deaths could significantly ramp up demand for these companies' existing and pipeline products.

Via The Motley Fool

Topics Death

3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street ↗

July 15, 2021

Analysts' high-water price targets imply some serious gains for these companies.

Via The Motley Fool

Topics Economy

Don’t Count on a Covid-19 Boost for Vaxart ↗

July 14, 2021

VXRT stock remains a speculative bet as the company's chance to develop an oral Covid-19 vaccine grows slimmer every day.

Via InvestorPlace

New Developments Have Made Vaxart Stock So Much More Attractive ↗

July 13, 2021

Vaxart recently made a licensing deal, and two research firms issued upbeat assessments of the company, making me more upbeat on VXRT stock.

Via InvestorPlace

Watch Out for a Selloff in Vaxart Stock ↗

July 09, 2021

VXRT stock's price may drop as their oral inoculation waits in the wings while other vaccine manufacturers take over the market.

Via InvestorPlace

Vaxart Inks Antiviral Asset Licensing Pact With Altesa Biosciences ↗

July 07, 2021

Vaxart Inc (NASDAQ: VXRT) has granted Altesa Biosciences Inc an exclusive worldwide license to develop and commercialize Vaxart's patented...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.